Inclusion Criteria:

- Infants under 6 months

- Presenting a hemangioma with the following characteristics:

- subcutaneous and / or cutaneous

- minimum diameter of 1.5cm on face, 5cm outside face and 3cm if it is ulcerated.

- without functional impairment requiring treatment or vital corticosteroid

- Consent of both parents (or the person having parental authority in families)

- Which at least one parent is a beneficiary of a social security system.

Exclusion Criteria:

- Indication of treatment with corticosteroids for an indication other than hemangioma

- Indication of treatment with beta-blocker for another indication that the hemangioma

- Infant presenting cons-indications for the administration of acebutolol or
propranolol:

- Asthma and chronic obstructive pulmonary disease in their severe forms.

- Heart failure controlled by treatment.

- Cardiogenic shock

- Prinzmetal Angina

- Bradycardia (<80 beats / min at rest the first month <70/minute from 1 to 6
month).

- Raynaud's phenomenon and peripheral arterial disorders in their severe forms.

- Pheochromocytoma untreated.

- Low blood pressure (blood pressure <60/30 mmHg before 6 months)

- Hypersensitivity to acebutolol or propranolol

- History of anaphylactic reaction.

- Treatment with amiodarone and / or calcium channel blockers.

- Congenital heart disease outside inter auricular communication (CIA) or inter
ventricular communication (CIV) insignificant